Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.93ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.93ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.93EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.93EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.93ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.93ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.104EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.104EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.104ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.104ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.104EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.104EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.104ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.104ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.177.4EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.177.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.177.4ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.177.4ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.177.4EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.177.4EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.177.4ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.177.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.177.6EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.177.6EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.177.6ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.177.6ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.177.6EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.177.6EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.177.6ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.177.6ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.560EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.560EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.560ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.560ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.560EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.560EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.560ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.560ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.610EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.610EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.610ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.610ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.610EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.610EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.610ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.610ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AY.10 (Delta)EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
AY.10 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.10 (Delta)ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
AY.10 (Delta)ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used